Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy
Daniela Paola Roggeri, Alessandro Roggeri ProCure Solutions, Nembro, Bergamo, Italy Purpose: Hepatic encephalopathy (HE) is associated with a reduced survival, an increased risk of hospitalization for recurrences, and a reduced health-related quality of life. The purpose of the present econ...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-09-01
|
| Series: | Hepatic Medicine : Evidence and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/economic-impact-of-the-use-of-rifaximin-550-mg-twice-daily-for-the-tre-peer-reviewed-article-HMER |